6 unknown, 1 not yet recruiting, 1 recruiting. 8 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Unknown 6, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 2 | Recruiting 1, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow iguratimod: new trials by email Literature Review of iguratimod trials Research Report on iguratimod
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP Iguratimod, low-dose rituximab - Immune Thrombocytopenia (ITP) | Phase 2 | Not yet recruiting | Peking University People's Hospital | 120 | 2025-07-01 | 2025-07-10 |
| Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHD Iguratimod - cGVHD | Phase 1 / Phase 2 | Recruiting | Xuzhou Medical University | 20 | 2024-01-10 | 2026-09-30 |
| Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia Iguratimod - Immune Thrombocytopenia | Phase 2 | Unknown | Peking University People's Hospital | 100 | 2022-03-22 | 2022-03-31 |
| Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO) Iguratimod, placebo - Hand Osteoarthritis, Inflammatory Arthritis | Phase 2 / Phase 3 | Unknown | Peking University People's Hospital | 150 | 2022-03-01 | 2022-02-08 |
| The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia Iguratimod, Danazol - ITP, Immune Thrombocytopenia | Phase 2 | Unknown | Peking University People's Hospital | 120 | 2021-09-01 | 2022-05-02 |
| A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome. Iguratimod, Placebo - Primary Sjögren Syndrome | Phase 2 | Unknown | Jiangsu Simcere Pharmaceutical Co., Ltd. | 144 | 2021-03-22 | 2021-07-19 |
| The Iguratimod Effect on Lupus Nephritis (IGeLU) Iguratimod, Cyclophosphamide, Azathioprine - Lupus Nephritis | Phase 2 | Unknown | RenJi Hospital | 120 | 2017-09-07 | 2018-12-19 |
| Study of Iguratimod in Sjögren's Syndrome Iguratimod - Sjogren's Syndrome | Phase 1 / Phase 2 | Unknown | Peking Union Medical College Hospital | 30 | 2017-02-01 | 2017-01-18 |
Purpura, Thrombocytopenic, Idiopathic (3) · Arthritis (1) · Lupus Nephritis (1) · Nephritis (1) · Sjogren's Syndrome (1)
Peking University People's Hospital (4) · Jiangsu Simcere Pharmaceutical Co., Ltd. (1) · Peking Union Medical College Hospital (1) · RenJi Hospital (1) · Xuzhou Medical University (1)
China (7)
Xiao-Hui Zhang, MD (2) · Chunde Bao, MD (1) · Xiaohui Zhang (1) · Yan Zhao, Dr. (1)